In the relentless fight against malaria, particularly the deadly Plasmodium falciparum strain, late treatment failure stands as a formidable barrier to global health progress, characterized by the reappearance of malaria parasites in the bloodstream after an initially successful drug response. This
The pharmaceutical industry stands as a pillar of modern healthcare, tirelessly working to develop life-saving medications through rigorous research and development efforts that often span years and cost billions. Yet, the very system designed to protect and incentivize this innovation—the patent
In a chilling development for healthcare systems across the United States, a dramatic increase in multidrug-resistant bacteria known as carbapenemase-producing carbapenem-resistant Enterobacterales (CP-CRE) has emerged as a formidable challenge in hospitals, often dubbed a "superbug" due to its
In the heart of New Orleans, a small HIV outreach ministry faces an impossible choice: cut essential supplies like condoms or lay off staff who keep the operation running, reflecting a broader crisis rippling across the United States in 2025. Behind closed doors, Russell Vought, director of the
In the fast-paced realm of pharmaceutical advancements, few stories capture attention like the regulatory journey of Sanofi’s tolebrutinib, a potential game-changer for non-relapsing secondary progressive multiple sclerosis (nrSPMS). This Bruton’s tyrosine kinase (BTK) inhibitor, aimed at slowing
Cardiovascular disease (CVD) stands as a formidable global health challenge, claiming roughly one-third of all deaths worldwide in 2023, according to the most extensive analysis yet from the Global Burden of Disease (GBD) Study. Spanning data across 204 countries and territories over more than
